Boundlessbio.com

Boundlessbio.com has Server used 141.193.213.21 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2019-06-29 (1 year, 323 days) and hosted in Del Mar United States, server ping response time 20 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Boundlessbio keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Boundlessbio.com
2 Boundless bio
3 Boundless biomes
4 Boundless biotech
5 Boundless biology
6 Boundless biosciences
7 Boundless biochemistry
8 Boundless bio address
9 Boundless bio bloomberg

Hosting Provider

Website: Boundlessbio.com
Hostname: 141.193.213.21
Country:
Region: CA
City: Del Mar
Postal Code: 92014
Latitude: 32.96720123291
Longitude: -117.25859832764
Area Code: 858
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Agssmc.org (21 seconds ago)

   » Iconr.com (5 seconds ago)

   » Thetravelgiraffe.com (3 seconds ago)

   » Designsystemsrepo.com (3 seconds ago)

   » Micklawpc.com (12 seconds ago)

   » Avonmotorsport.com (4 seconds ago)

   » Tamuk.edu (4 seconds ago)

   » Rblys.com (3 seconds ago)

   » Echo-media.com (1 min ago)

   » Baohiemmanulifesaigon.com (8 seconds ago)

Results For Websites Listing

Found 46 Websites with content related to this domain, It is result after search with search engine

Boundless Bio LinkedIn

Linkedin.com   DA: 16 PA: 21 MOZ Rank: 37

Boundless Bio, a San Diego based company backed by ARCH Venture Partners, is discovering and developing novel cancer therapeutics based on the role of …

Startup Boundless Bio Brings In $105M To Break The Circle

Medcitynews.com   DA: 15 PA: 50 MOZ Rank: 66

  • Boundless Bio’s research has uncovered a previously unknown driver of cancer growth and drug resistance
  • With $105 million in Series B financing, the biotech is on a path to bring to the clinic

Boundless Bio Secures $105 Million To Advance Oncology

Startupsavant.com   DA: 17 PA: 28 MOZ Rank: 47

  • About Boundless Bio Launched in 2019, Boundless Bio is a biopharmaceutical company that is working to develop an entirely new class of transformative, innovative oncology therapies to treat ecDNA in aggressive, intractable cancers
  • The business states that ecDNA are small circles of DNA outside of the chromosome still confined within the nucleus.

Boundless Bio Company Profile

Craft.co   DA: 8 PA: 14 MOZ Rank: 25

  • Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers
  • It offers cancer drugs and extrachromosomal DNA (ecDNA) that eliminate cancer cells' ability to employ ecDNA to survive, enabling healthcare professionals to treat most-difficult cancers.

Boundless Bio Announces Upcoming Presentation At The

Businesswire.com   DA: 20 PA: 29 MOZ Rank: 53

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with

Boundless Biology Simple Book Publishing

Courses.lumenlearning.com   DA: 25 PA: 19 MOZ Rank: 49

  • Copyright This courseware includes resources copyrighted and openly licensed by multiple individuals and organizations
  • Click the words "Licenses and Attributions" at

Boundless Bio Announces Educational Session On

Biospace.com   DA: 16 PA: 50 MOZ Rank: 72

Boundless Bio Announces Educational Session on Extrachromosomal DNA (ecDNA) at the American Association for Cancer Research (AACR) Annual Meeting 2021 - read this article along with other careers information, tips and advice on BioSpace

Boundless Bio VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 77

"Boundless Bio is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers.

San Diego Startup Raises Nearly $47 Million For New

Sandiegouniontribune.com   DA: 28 PA: 48 MOZ Rank: 84

  • Boundless Bio was organized this year, Hornby said
  • He was chief operating officer of Ignyta, a San Diego biotech purchased in December 2017 for $1.7 billion in cash

Boundless Bio Launches To Deliver Transformative Therapies

Businesswire.com   DA: 20 PA: 50 MOZ Rank: 79

Boundless Bio is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously

Boundless Bio Raises $105M In Effort To Reimagine Targeted

Endpts.com   DA: 10 PA: 50 MOZ Rank: 70

Bound­less Bio is go­ing af­ter can­cer cells that con­tain ex­tra bits of cir­cu­lar DNA, float­ing around out­side the tight­ly wound chro­mo­somes where the ge­net­ic code is sup­posed to sit.

Boundless Bio Company Profile: Valuation & Investors

Pitchbook.com   DA: 13 PA: 27 MOZ Rank: 51

Developer of novel cancer therapeutics designed to deliver transformative therapies to patients with previously intractable cancers.

Boundless Bio : Announces Educational Session On

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 84

18 hours ago · Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced that scientific founders, Paul Mischel, M.D., Roel Verhaak, Ph.D., and Howard Chang, M.D., Ph.D., will participate in an educational session at the 2021 American …

Boundless Bio Brings In $105M PitchBook

Pitchbook.com   DA: 13 PA: 40 MOZ Rank: 66

Boundless Bio has raised a $105 million Series B co-led by RA Capital Management and Nextech Invest.The San Diego-based company is developing cancer treatment therapies; it was valued at $70.9 million in 2019, according to PitchBook data.

Boundless Bio Presents Data On The Role Of

Preipopharma.com   DA: 20 PA: 50 MOZ Rank: 84

  • Boundless Bio Presents Data on the Role of Extrachromosomal DNA (ecDNA) in Mediating Resistance to Targeted Therapies at the American Association for Cancer Research (AACR) Annual Meeting 2021
  • Tags: Oncology AACR The study validates that ecDNA is a driver of cancer by providing a fitness advantage for tumor cells through oncogene copy number

Boundless Bio Raises Oversubscribed $105 Million Series B

Register-herald.com   DA: 23 PA: 50 MOZ Rank: 88

Boundless Bio’s Spyglass™ platform is a comprehensive suite of proprietary ecDNA-driven and pair-matched tumor models along with proprietary imaging and molecular analytical tools that enables

Wilson Sonsini Advises Boundless Bio On IP Matters Related

Wsgr.com   DA: 12 PA: 50 MOZ Rank: 78

  • On April 28, 2021, Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, announced the closing of an oversubscribed $105 Million Series B financing
  • RA Capital Management and Nextech Invest co-led the financing, with participation from a top …

Boundless Bio Raises Oversubscribed $105 Million Series B

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 83

Boundless Bio's Spyglass™ platform is a comprehensive suite of proprietary ecDNA-driven and pair-matched tumor models along with proprietary imaging and molecular analytical tools that enables

Boundless Bio Presents Data On The Role Of

Biospace.com   DA: 16 PA: 50 MOZ Rank: 84

  • Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers
  • For more information, visit www.boundlessbio.com
  • Follow us on LinkedIn and Twitter.

Boundless Bio Raises $105M In Series B Financing

Precisiononcologynews.com   DA: 29 PA: 50 MOZ Rank: 98

  • NEW YORK – Boundless Bio said on Wednesday it has raised $105 million in a Series B funding round led by Nextech Invest and RA Capital Management
  • New investors that participated in the funding round included Fidelity Management & Research, Redmile Group, Wellington Management, Surveyor Capital

Boundless Bio Raises $46M In Series A Funding FinSMEs

Finsmes.com   DA: 15 PA: 50 MOZ Rank: 85

Boundless Bio was founded by a team of pioneering cancer researchers, led by Paul Mischel, M.D., a Distinguished Professor at the University of California San Diego (UC San Diego) School of

Boundless Bio Uncloaks With $46M To Create New Cancer

Fiercebiotech.com   DA: 21 PA: 50 MOZ Rank: 92

Boundless Bio was founded on a discovery that a group of cancer-driving mutations called amplifications occur in extrachromosomal DNA, or DNA that resides outside of the chromosome in cancer cells.

Boundless Bio Presents Data On The Role Of

Streetinsider.com   DA: 21 PA: 50 MOZ Rank: 93

Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with

Boundless Bio Launches To Exploit Burgeoning Understanding

Cen.acs.org   DA: 11 PA: 50 MOZ Rank: 84

  • Boundless Bio has formally launched with $46.4 million in funding from Arch Venture Partners and City Hill Ventures
  • The San Diego–based biotech firm hopes to prevent the proliferation of

Boundless Biohacker – Learn How To Leverage Your Biology

Boundlessbiohacker.com   DA: 22 PA: 22 MOZ Rank: 68

  • This is an example post, originally published as part of Blogging University
  • Enroll in one of our ten programs, and

Boundless Bio Presents Data On The Role Of

Sdbn.org   DA: 8 PA: 50 MOZ Rank: 83

Home News Boundless Bio Presents Data on the Role of Extrachromosomal DNA (ecDNA) in Mediating Resistance to Targeted Therapies at the American Association for Cancer Research (AACR) Annual Meeting 2021 Boundless Bio Presents Data on the Role of Extrachromosomal DNA (ecDNA) in Mediating Resistance to Targeted Therapies at the …

Boundless Bio Announces Educational Session On

Streetinsider.com   DA: 21 PA: 50 MOZ Rank: 97

Boundless Bio Announces Educational Session on Extrachromosomal DNA (ecDNA) at the American Association for Cancer Research (AACR) Annual Meeting 2021 Article FREE Breaking News Alerts from

Org Chart Boundless Bio

Theofficialboard.com   DA: 24 PA: 24 MOZ Rank: 75

  • Boundless Bio has 12 executives
  • Boundless Bio; Please confirm your deletion
  • Unfortunately, you don't own enough credit to see this new org chart
  • To continue, you can add a name in one of the org charts you recently viewed or test our Premium

Boundless Bio Appoints Christian Hassig, Ph.D., As Chief

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 95

About Boundless Bio Boundless Bio is a biotechnology company committed to interrogating a previously unexplored dimension in cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative

Boundless Bio Snags $105m Series B Venture Capital Journal

Venturecapitaljournal.com   DA: 29 PA: 35 MOZ Rank: 93

  • Boundless Bio, a next-generation precision oncology company, has secured $105 million in Series B financing
  • RA Capital Management and Nextech Invest led the round.

Boundless Bio Pulls In $46.4M Series A

Vcnewsdaily.com   DA: 15 PA: 49 MOZ Rank: 94

  • About Boundless Bio Boundless Bio is a biotechnology company focused on interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers
  • For more information, visit www.boundlessbio.com.

Boundless Bio Raises Oversubscribed $105 Million Series B

Preipopharma.com   DA: 20 PA: 50 MOZ Rank: 19

  • Boundless Bio is a next-generation precision oncology company interrogating a novel area of cancer biology, extrachromosomal DNA (ecDNA), to deliver transformative therapies to patients with previously intractable cancers
  • For more information, visit www.boundlessbio.com.

Job Application For Director/Senior Director

Boards.greenhouse.io   DA: 20 PA: 29 MOZ Rank: 81

  • Boundless Bio is a San Diego-based, next generation precision oncology company employing an exciting new area of cancer biology, extrachromosomal DNA ("ecDNA"), to revolutionize the way cancer is treated
  • Due to its position as the foremost company developing innovative therapeutics directed against ecDNA, Boundless recently concluded an

Job Application For Chief Business Officer At Boundless Bio

Boards.greenhouse.io   DA: 20 PA: 29 MOZ Rank: 82

  • Boundless Bio is a San Diego-based, next generation precision oncology company employing an exciting new area of cancer biology, extrachromosomal DNA (“ecDNA”), to revolutionize the way cancer is treated
  • Due to its position as the foremost company developing innovative therapeutics directed against ecDNA, Boundless recently concluded an

BOUNDLESS BIO, INC. :: California (US) :: OpenCorporates

Opencorporates.com   DA: 18 PA: 25 MOZ Rank: 77

  • Free and open company data on California (US) company BOUNDLESS BIO, INC
  • (company number C4187720), 11099 N

Boundless Reviews Glassdoor

Glassdoor.com   DA: 17 PA: 38 MOZ Rank: 90

  • There is a small business atmosphere in the office that is unmatched by other companies
  • Everyone is very warm and inviting, and …

Recently Analyzed Sites

Agssmc.org (21 seconds ago)

Iconr.com (5 seconds ago)

Thetravelgiraffe.com (3 seconds ago)

Designsystemsrepo.com (3 seconds ago)

Sdbsa.com (0 seconds ago)

Avonmotorsport.com (4 seconds ago)

Tamuk.edu (4 seconds ago)

Rblys.com (3 seconds ago)

Echo-media.com (1 min ago)

Ccautobrokers.com (4 seconds ago)

Boundlessbio.com (1 seconds ago)

Medicalhair4u.com (1 seconds ago)

Ansicht.net (4 seconds ago)

Hamutd.com (6 seconds ago)

Robinsonsbrewery.com (6 seconds ago)

Bakermusttravel.com (2 seconds ago)